This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Miller, W. L. Articles by Jaffe, A. S. Search for Related Content PubMed Articles by Miller, W. L. Articles by Jaffe, A. S. Related Collections Other heart failure

(Circulation. 2008;117:e24.)
© 2008 American Heart Association, Inc.

Correspondence

Response to Letter Regarding Article, "Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time"

Wayne L. Miller, MD, PhD; Karen A. Hartman, BSN, CCRC; Diane E. Grill, MSc; Mary F. Burritt, PhD; Richard J. Rodeheffer, MD; John C. Burnett, Jr, MD; Allan S. Jaffe, MD

Mayo Clinic, Rochester, Minn

An extract of the first 250 words of the full text is provided, because this article has no abstract.

We thank Drs Ballo, Bocelli, and Mondillo for their interest in our recent article.¹ They raise an interesting issue relating to the finding in our study cohort that cardiac resynchronization therapy (CRT) was associated with adverse effects. They point out correctly that in several reports, CRT and brain natriuretic peptide (BNP) are associated with clinical benefit and that over time, as in our longitudinal study, a reduction in BNP levels occurs (CARE-HF).² Thus, they express a concern that this known collinearity of BNP and CRT, albeit for different outcomes, could have confounded the multivariate model relating baseline risk factors to the outcome of death and cardiac transplantation in this patient cohort. This is a reasonable possibility to explore, as we have done.

It is important to keep in mind the context of our findings and to appreciate that only 27 patients (14% of the study cohort) received CRT, making a more comprehensive analysis of this subset problematic. In addition, many of these patients received CRT early after its introduction, given the relatively long timeline of our study. Thus, some of these patients likely were those with more severe disease that characterized the patients selected at that time for this type of therapy. However, statistical confounding is also possible. To address the concern that a strong association between the independent variables of BNP elevation and CRT (collinearity) could have affected the resulting coefficient in the model (Table 3 in our article¹), we re-analyzed the multivariate model without the CRT variable. . . . [Full Text of this Article]